Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00804284 · ClinicalTrials.gov registry record
Database Surveillance Safety Study of PENTACEL® Vaccine
A clinical trial, sponsored by Sanofi Pasteur, a Sanofi Company.
- Completed
- Registry status
- 62,538
- Enrollment target
NCT00804284 is a clinical trial that has completed, run by Sanofi Pasteur, a Sanofi Company. The registered enrollment target is 62,538 participants.
The verdict
NCT00804284 has completed, sponsored by Sanofi Pasteur, a Sanofi Company.
- COMPLETED
- Registry status
- 62,538 participants
- Enrollment target
Study Summary
The objective for this study is to characterize the safety profile of PENTACEL® vaccine for identification of potential vaccine-related adverse events not currently associated with PENTACEL® vaccine administration.
Interventions
- BIOLOGICAL DTaP-IPV/Hib
- BIOLOGICAL Other DTap Vaccines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62,538 participants |
| Start Date | 2008-09 |
| Est. Completion | 2015-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00804284
The ClinicalTrials.gov registry entry for NCT00804284 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 62,538 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi Pasteur, a Sanofi Company, which has 153 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DTaP-IPV/Hib is the first listed.
NCT00804284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00804284 about?
NCT00804284 is a clinical study titled "Database Surveillance Safety Study of PENTACEL® Vaccine". The objective for this study is to characterize the safety profile of PENTACEL® vaccine for identification of potential vaccine-related adverse events not currently associated with PENTACEL® vaccine administration.
What is the current status of trial NCT00804284?
This trial is currently completed. The enrollment target is 62,538 participants. The study started on 2008-09. Estimated completion is 2015-01.
What interventions are being tested in trial NCT00804284?
The interventions under investigation include: DTaP-IPV/Hib (BIOLOGICAL), Other DTap Vaccines (BIOLOGICAL).
Who is sponsoring clinical trial NCT00804284?
This trial is sponsored by Sanofi Pasteur, a Sanofi Company, which has 153 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.